Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide; telmisartan - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; telmisartan and what is the scope of hydrochlorothiazide; telmisartan freedom to operate?

Hydrochlorothiazide; telmisartan
is the generic ingredient in two branded drugs marketed by Alembic Pharms Ltd, Aurobindo Pharma Ltd, Mylan Pharms Inc, Lupin Ltd, Boehringer Ingelheim, Macleods Pharms Ltd, and Torrent Pharms Ltd, and is included in seven NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Hydrochlorothiazide; telmisartan has forty-two patent family members in thirty-four countries.

There are thirty-one drug master file entries for hydrochlorothiazide; telmisartan. Twelve suppliers are listed for this compound.

Summary for Generic Name: hydrochlorothiazide; telmisartan

Drug Master File Entries: see list31
Suppliers / Packagers: see list12
Bulk Api Vendors: see list6
Clinical Trials: see list118
Patent Applications: see list12
Drug Prices:see low prices
DailyMed Link:hydrochlorothiazide; telmisartan at DailyMed

Pharmacology for Ingredient: hydrochlorothiazide; telmisartan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Macleods Pharms Ltd
hydrochlorothiazide; telmisartan
TABLET;ORAL204169-001Nov 2, 2015ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
hydrochlorothiazide; telmisartan
TABLET;ORAL091351-001Aug 7, 2014ABRXNoNo► Subscribe► Subscribe
Alembic Pharms Ltd
hydrochlorothiazide; telmisartan
TABLET;ORAL203010-003Feb 25, 2014ABRXNoNo► Subscribe► Subscribe
Alembic Pharms Ltd
hydrochlorothiazide; telmisartan
TABLET;ORAL203010-001Feb 25, 2014ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
hydrochlorothiazide; telmisartan
TABLET;ORAL091648-002Feb 25, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus